The U.S. Centers for Disease Control and Prevention has received reports of several cases of malaria in Haiti since a 7.0 magnitude earthquake struck the country Jan. 12.
The U.S. Centers for Disease Control and Prevention has received reports of several cases of malaria in Haiti since a 7.0 magnitude earthquake struck the country Jan. 12.
CHICAGO — King Tutankhamen, the teenaged pharaoh whose Egyptian tomb yielded dazzling treasures, limped around on tender bones and a clubfoot and probably died from malaria, researchers said Feb. 16.
The first results from a study of key anti-malarial medicines reveal that a high percentage of medicines circulating on national markets are of substandard quality and may contribute to the growth of drug-resistant strains of malaria.
Researchers at the University of Copenhagen have become the first in the world to synthesize the entire protein that is responsible for life-threatening malaria in pregnant women and their unborn children, ScienceDaily reported Feb. 5.
Research done at Singapore's Nanyang Technological University's School of Biological Sciences could lead to the development of more potent drugs or a vaccine for malaria, ScienceDaily reported Feb. 5.
A new vaccine tested in 100 West African children triggers the immune system to produce antibodies against the malaria parasite at levels normally seen only in adults who have strong resistance to the disease.
Médecins Sans Frontières teams in Burundi's Kayanza province assessing and treating patients in the midst of a rise in the incidence of malaria, the organization also known as Doctors Without Borders reported Jan. 29.
NANORO, Burkina Faso — The Phase 3 trial of GlaxoSmithKline Biologicals' RTS,S, a malaria vaccine candidate, is on track.
A biomedical researcher at the University of Central Florida has developed what promises to be the first low-cost dual vaccine against malaria and cholera, school officials announced Jan. 26.
Microsoft founder Bill Gates has told the BBC that a vaccine for malaria could be just three years away.
SYDNEY — Researchers in Australia say a group of proteins produced in the human immune system when it is infected with malaria could help lead to the creation of a malaria vaccine, Voice of America reported Jan. 20.
The parasite that causes malignant malaria in humans has been detected in gorillas, according to a study co-authored by biologist Francisco Ayala of the University of California, Irvine.
LONDON — The chief executive of the world's second biggest pharmaceutical company will announce Jan. 20 that he is putting into the public domain thousands of potential drugs that might cure malaria, The Guardian reported.
BETHESDA, Md. — The PATH Malaria Vaccine Initiative announced a new collaboration Jan. 15 to initiate development toward a vaccine that may eventually help eliminate and eradicate malaria.
PHNOM PENH, Cambodia — Cambodia has seen a rise in reported cases of dengue fever and malaria in 2009, local media reported Jan. 5, citing health officials here.
SAN DIEGO — Researchers from the La Jolla Institute for Allergy & Immunology will take aim at several of the world's most dangerous infectious diseases — tuberculosis, malaria and dengue virus.
An experimental nasally administered malaria vaccine prevented parasite transmission from infected mice to mosquitoes and could play an important role in the fight against human malaria, ScienceDaily reported Dec. 20.
Malaria parasites are able to disguise themselves to avoid the host's immune system, according to research funded by the Wellcome Trust and published Dec. 1 in the journal Proceedings of the National Academy of Sciences.
ATLANTA -- There were ten cases of malaria reported across the United States during the week ending October 10th, four of which occurred in Virginia.
HONG KONG — In a laboratory in China's southern city of Guangzhou, scientists are trying to enhance the rare sweet wormwood shrub, from which artemisinin — the best drug to fight malaria — is derived.
NAIROBI, KENYA — A pivotal efficacy trial of RTS,S, the world’s most clinically advanced malaria vaccine candidate, is under way in seven African countries.
LONDON —More than 5,500 children across Africa have been given an experimental new malaria vaccine and the British drugmaker behind it, GlaxoSmithKline, promised Oct. 28 that price would be no hurdle if it works.